609.16MMarket Cap-3611P/E (TTM)
5.410High4.750Low7.91MVolume5.410Open5.340Pre Close38.94MTurnover8.66%Turnover RatioLossP/E (Static)125.86MShares9.97052wk High-9.57P/B441.92MFloat Cap2.43052wk Low--Dividend TTM91.31MShs Float17.450Historical High--Div YieldTTM12.36%Amplitude1.960Historical Low4.922Avg Price1Lot Size
Humacyte Stock Forum
what happened? the earnings suck but now the stock is rising
Do you think that is a credibility issue maybe they raise this company some money along the way and they need to be bullish to get potential business from them in the future.
Humacyte Announces Presentation of Positive Results from V007 Phase 3 AV Access Clinical Trial at the American Society of Nephrology’s Kidney Week 2024
Humacyte (HUMA) presented positive Phase 3 clinical trial results for their ATEV (acellular tissue engineered vessel) in arteriovenous access for hemodialysis patients. The trial demonstrated superior performance compared to standard autogenous fistula, with 81.3% functional patency at 6 months versus 66.4%, and 68.3% seco...
+20% today 😃
1 min ago
Humacyte Announces Allowance of U.S. Patent Covering Biovascular Pancreas (Bvp™)
No comment yet